Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cerebral blood flow and neuronal membrane integrity refer to a set of physiological parameters and structural states essential for maintaining central nervous system function. Cerebral blood flow (CBF) is the rate of blood delivery to the brain, which is tightly regulated via neurovascular coupling to meet the high metabolic demands of neurons (StatPearls, 2023, 'Physiology, Cerebral Blood Flow'). Neuronal membrane integrity describes the structural and functional stability of the lipid bilayer, which is vital for signal transduction, ion gradient maintenance, and protecting the cell from oxidative stress (Grieb, P., 2014, PubMed). Impairment of these factors is a common feature in neurodegenerative conditions like Alzheimer's disease and acute events like ischemic stroke (Zlokovic, B. V., 2011, 'Neurovascular pathways to neurodegeneration', Nature). Pharmacological agents such as Citicoline or Nimodipine are used to support these processes by either promoting phospholipid synthesis or enhancing microcirculation. However, because this entry describes a physiological outcome or clinical endpoint rather than a specific protein, gene, or receptor, it is classified as a biological state rather than a discrete therapeutic target.
Drugs affecting these parameters work through diverse mechanisms: Citicoline (CDP-choline) acts as a rate-limiting intermediate in the biosynthesis of phosphatidylcholine, thereby repairing and stabilizing neuronal membranes (Grieb, P., 2014, 'Therapeutic Potential of Citicoline', PubMed). Nimodipine acts as a calcium channel blocker that induces cerebral vasodilation to increase blood flow (StatPearls, 2023, 'Nimodipine').
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cerebral blood flow and neuronal membrane integrity.